COH:ASX
Cochlear Ltd
A$128,64
arrow_upward
+0,19%(+0,25) 1D
12 ຕ.ລ., 12 ໂມງ 50 ນາທີ 32 ວິນາທີ GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COH...
Open
A$128,15
High
A$130,79
Low
A$127,01
Mkt. cap
8,41 ຕື້
Avg. vol.
732,58 ພັນ
Volume
130,93 ພັນ
Dividend
2,68%
Quarterly dividend
A$0,86
Ex-dividend date
21 ກ.ຍ. 2026
P/E ratio
57,23
52-wk high
A$296,50
52-wk low
A$88,74
EPS
A$2,25
Shares outstanding
65,40 ລ້ານ
No. of employees
5 ພັນ
Open
A$128,15
High
A$130,79
Low
A$127,01
Mkt. cap
8,41 ຕື້
Avg. vol.
732,58 ພັນ
Volume
130,93 ພັນ
Dividend
2,68%
Quarterly dividend
A$0,86
Ex-dividend date
21 ກ.ຍ. 2026
P/E ratio
57,23
52-wk high
A$296,50
52-wk low
A$88,74
EPS
A$2,25
Shares outstanding
65,40 ລ້ານ
No. of employees
5 ພັນ
News stories
From web sources and news partners
TipRanks
·
4 ຊົ່ວໂມງກ່ອນ
BNY Mellon Ceases to Be Substantial Holder in Cochlear
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5,4 ພັນ
Founded1981
Headquartersຊີດນີ, ນິວ ເຊົາ ເວລ, ອອສເຕຣເລຍ
SectorMedical device
Websitecochlear.com